alternatives to glp-1 weight loss medications Medication Agonists (Ozempic, Wegovy, Zepbound) Liraglutide vs Semaglutide vs GLP-1
Description
14% in placebo-treated individuals
in vivo and in vitro studies
GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective
YJZ: Conceptualization, Formal Analysis, Writingoriginal draft
The ADJUNCT ONE trial found that symptomatic hypoglycemia had a dose-related effect with a rate ratio between 1.27 and 1.31 on doses of 1.2 and 1.8 mg of liraglutide, respectively
D'Marco L., Morillo V., Gorriz J.L., Suarez M.K., Nava M., Ortega ., et al
